Decera Clinical Education

🍃 Featured Faculty Spotlight: Kristin N. Maher, MD, PhD! Join us at our Friday Satellite Symposium before #ASH2025 for evidence-based strategies shaping the future of non-factor replacement therapy.

👉 Learn more: https://bit.ly/48oyKn3

#HematologyEducation #CME #MedicalEducation

How do we advance migraine care? Together. 🤝 Watch our on demand video, earn #CME: https://bit.ly/48BvrtZ

Experience our new look in person at #ASH25 👀✨
Decera Clinical Education (formerly CCO) is making its debut!
Visit us at Booth 142.

Explore Decera Clinical Education: https://bit.ly/3XD4G1Z

#ASH2025 #HematologyEducation #MedicalEducation #DeceraClinical

🔥 Spotlight: Dr. Michael D. Jain

A leader in CAR T–cell therapy ahead of #ASH2025.
Join our Hematology Symposia, register in-person or online: https://bit.ly/4nyUrXZ

#HematologySymposia #DeceraClinicalEducation

We’re now Decera Clinical Education (deh-SAIR-uh), formerly CCO. Our name has evolved, but our expert-led CME/CE and trusted medical education remain the same. Thank you for celebrating this next chapter with us! Learn more:

Learn more → deceraclinical.com/education/co...

Relapsed/Refractory DLBCL: Patient-Provider Communication Checklist Infographic resource and checklist with a brief overview of relapsed/refractory diffuse large B-cell Lymphoma, with highlight information on treatment options, and sample question to ask the care team...

This easy-to-use checklist helps patients and providers communicate openly about treatment options and next steps in care.

💬 Download the infographic to support confident, informed conversations: https://bit.ly/46EATeK

We have a few exciting events coming up this week!

View all our events here 👉 https://bit.ly/4468zjw

The best part? It’s not too late to register and join us!

For more events this year, click here: https://bit.ly/46gSR6U

Extensive-Stage Small-Cell Lung Cancer With Recent Therapeutic Advancements for First-line Therapy Download these slides on current and emerging treatment strategies for extensive-stage SCLC (ES-SCLC), with a focus on key highlights of recent clinical trial data to shed light on the role of chemoim...

Download this expert-curated slideset on extensive-stage small-cell lung cancer (ES-SCLC) to review current and emerging strategies for first-line treatment, including new clinical trial data on chemoimmunotherapy and optimizing maintenance therapy.
👉 Access the slides here: https://bit.ly/4owLHSF

Download this patient–provider communication checklist for key information on treatment for newly diagnosed HER2+ metastatic breast cancer and questions to guide conversations with your doctor about treatment decisions.

Download here: https://bit.ly/3WUYZMD

#HER2 #CME #MedicalEducation

☕ Worry Free in HAE: Coffee Talks With the Experts! Explore the latest advances in long-term prophylaxis for hereditary angioedema (HAE) with this expert-curated downloadable slideset.

Download: https://bit.ly/3JudZho

#HereditaryAngioedema #HAE #Prophylaxis #MedicalEducation

✨ New Resource Available! ✨ This slideset highlights the importance of diagnosing heart failure early.

📑 Access the slides here: https://bit.ly/4qzc1Nr

#HeartFailure #PatientCare #MedicalEducation

We have a few medical education events this week! See what events you can join this week!

✨👉 View events here: https://clinicaloptions.com/events?startdate=11/03/2025&enddate=11/09/2025

#CME #MedicalEducation

BIG NEWS! CCO will soon be known by a new name! We’re evolving into Decera Clinical Education (deh-SAIR-uh).

Everything you value about your experience will stay the same, and soon, you’ll gain access to new opportunities to learn, connect, and grow.

Obesity treatment is a team sport. ✨ From primary care providers and specialists to mental health professionals, physical therapists, and dietitians, each role can make a difference in a patient’s long-term success. Watch our new medical minute to see why: https://bit.ly/3KRmxiM

#MedicalEducation

Relapsed/Refractory DLBCL: Patient-Provider Communication Checklist Infographic resource and checklist with a brief overview of relapsed/refractory diffuse large B-cell Lymphoma, with highlight information on treatment options, and sample question to ask the care team.

Download the Relapsed/Refractory DLBCL: Patient-Provider Communication Checklist 📄 Empower patients and providers to work together toward better care.

Access the checklist here: https://bit.ly/46EATeK

🩺 Words matter in patient care. Just as we say “patients have cancer” rather than “cancer patients,” the same approach should guide conversations around overweight and obesity.

Watch here: https://bit.ly/3KRmxiM

Patient Perspectives on New Developments in PBC: Individualizing Patient Care With these slides, learn how recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Discover how you can integrate patient ...

✨ This slideset highlights how the latest advances in primary biliary cholangitis (PBC) are shifting the focus toward personalized care and symptom management.

📑 Access the slides here: https://bit.ly/4mVkp6T

#PBC #LiverDisease #PatientCare #MedicalEducation

Overcome the most common challenges when discussing vaccines with patients, parents, and caregivers.

Watch our new on-demand video: Experts in the Hot Seat! Powering Up Pediatric Vaccines Against Rising Resistance: https://bit.ly/3VTLWuo

#Vaccines #MedicalEducation

Nursing Management of Patients Receiving EGFR-Targeted Therapy for NSCLC: A Pocket Guide Download this pocket guide to help with the monitoring and management of adverse events associated with EGFR-targeted therapy for patients with NSCLC.

A Pocket Guide 💥💻 Nursing Management of Patients Receiving EGFR-Targeted Therapy for NSCLC! This quick reference resource helps nurses monitor and manage adverse events in patients receiving EGFR-targeted therapy.

👉 Download the PDF and keep it handy for everyday practice! https://bit.ly/481mElj

New Education article on HPV positive oropharyngeal cancer.

How can doctors spot this easily missed condition?

Includes #BMJInfographics that illustrate key points #MedEd
www.bmj.com/content/391/...

What is the risk of stroke associated with risperidone use in persons living with dementia?

New study (N=28k risperidone, 136k control) from UK Clinical Practice Research Datalink found ⬆️risk, esp. in those w/ previous stroke.

Helpful for quantifying risk vs benefit of risperidone use.

#medsky

Elucidating Multiple Sclerosis Treatment: Spotlight on Disease-Modifying Therapies Gain in-depth knowledge on evidence-based diagnostic criteria for multiple sclerosis and assessment of progression as well as strategies to increase patient adherence and characteristics to determine ...

🧠 Elucidating Multiple Sclerosis Treatment: Spotlight on Disease-Modifying Therapies
Build your expertise in MS care with a suite of on-demand resources designed for busy clinicians! 👉 https://bit.ly/3JQwEnq

Patient Resource: Understanding Treatment Options for HER2+ Gastroesophageal Adenocarcinoma (GEA) and Biliary Tract Cancer (BTC) Downloadable PDF resource as a helpful guide for patients in understanding treatment options for HER2+ GEA and BTC.

Download this resource for your patients! Patient Resource: Understanding Treatment Options for HER2+ Gastroesophageal Adenocarcinoma (GEA) and Biliary Tract Cancer (BTC) 💥👉 Download here: https://bit.ly/3IFIpge #HER2 #MedEd #EdSky

Making the Meningitis Conversation Count: Your Guide to Confident Meningitis Vaccine Discussions Download this shareable guide to learn how your words can help proactively prevent meningitis infection. This handy how-to features patient-friendly talking points for HCPs to use when discussing the ...

🧠💉The way we communicate matters. This practical, shareable guide equips HCPs with patient-friendly talking points to navigate meningitis vaccine discussions with confidence. Download: https://bit.ly/46sah0l

Improving AATD Care Through Early Diagnosis and Multidisciplinary Management: A Call to Action In this module, a gastroenterology/hepatology expert discusses the pathophysiology of alpha-1 antitrypsin deficiency (AATD), importance of early diagnosis, multidisciplinary management strategies, and...

Review the full module and earn CE/CME: clinicaloptions.com/activities/g...

#CE #CME #MedicalEducation

Although AATD is a genetic disease, the symptom causation is different in its related liver vs lung disease. Furthermore, the most common variant that is associated with both AATD-related lung and liver disease is the ZZ variant.3-6

Then the accumulation and improper polymerization of AAT in hepatocytes leads to liver disease.

In a longitudinal Swedish study, 7% of patients with AATD developed cirrhosis and 2% developed HCC. Lung disease in particular is related to AATD because reduced AAT leads to increased activity of neutrophil elastase in the lungs. This occurs because of a deficiency in the serum of functional AAT.

Overview of AATD: Liver vs Lung Disease

Approximately 50% of Americans with AATD, which is approximately 1 in every 3000 to 5000 people, may develop reduced lung function over time. In comparison, only approximately 10% of adults with AATD will go on to develop liver disease.

Download this pocket guide to help with the monitoring and management of long-term toxicities associated with CAR T-cell therapy!

Download here: https://bit.ly/3JD6ap7